GNAS and hepatocellular carcinoma: The following validation test, based on a large-scale serum sample set including 228 sera from HCC patients, 228 sera from LC patients, 228 sera from CHB patients, and 228 sera from NCs was conducted by ELISA to further detect and validate whether autoantibody to GNAS appeared with a trend in the patients at different stages.